Each year, the Patient Safety Group sets out core priority areas to work on.

In 2021 we will; continue to provide a forum based on the principles of sharing and learning, openness and transparency and will work to embed these principles at all levels; work with policy makers to inform national safety mechanisms; engage with key stakeholders and respond proactively and reactively to issues which impact patient safety. 

We will focus on the ongoing COVID-19 pandemic, medication errors, medication safety in pregnancy, resilience & wellbeing, LASA medicines, controlled drugs and opioid stewardship, long covid and safeguarding. 


The groups priorities from previous years can be viewed below.